141 related articles for article (PubMed ID: 37506884)
21. Targeting Metabolic Cross Talk Between Cancer Cells and Cancer-Associated Fibroblasts.
Jung JG; Le A
Adv Exp Med Biol; 2021; 1311():205-214. PubMed ID: 34014545
[TBL] [Abstract][Full Text] [Related]
22. Mutual impact of adipocytes and colorectal cancer cells growing in co-culture conditions.
Olszańska J; Pietraszek-Gremplewicz K; Domagalski M; Nowak D
Cell Commun Signal; 2023 Jun; 21(1):130. PubMed ID: 37316878
[TBL] [Abstract][Full Text] [Related]
23. Cancer-Associated Fibroblasts Promote Radioresistance of Breast Cancer Cells via the HGF/c-Met Signaling Pathway.
Wang B; Liu W; Liu C; Du K; Guo Z; Zhang G; Huang Z; Lin S; Cen B; Tian Y; Yuan Y; Bu J
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):640-654. PubMed ID: 36586496
[TBL] [Abstract][Full Text] [Related]
24. IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells.
Remsing Rix LL; Sumi NJ; Hu Q; Desai B; Bryant AT; Li X; Welsh EA; Fang B; Kinose F; Kuenzi BM; Chen YA; Antonia SJ; Lovly CM; Koomen JM; Haura EB; Marusyk A; Rix U
Sci Signal; 2022 Aug; 15(747):eabj5879. PubMed ID: 35973030
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
28. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
[TBL] [Abstract][Full Text] [Related]
30. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
31. Suppression of MAPK signaling in BRAF-activated PTEN-deficient melanoma by blocking β-catenin signaling in cancer-associated fibroblasts.
Zhou L; Yang K; Dunaway S; Abdel-Malek Z; Andl T; Kadekaro AL; Zhang Y
Pigment Cell Melanoma Res; 2018 Mar; 31(2):297-307. PubMed ID: 29045061
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment.
Dratkiewicz E; Simiczyjew A; Pietraszek-Gremplewicz K; Mazurkiewicz J; Nowak D
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877948
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated fibroblasts in digestive tumors.
Huang L; Xu AM; Liu S; Liu W; Li TJ
World J Gastroenterol; 2014 Dec; 20(47):17804-18. PubMed ID: 25548479
[TBL] [Abstract][Full Text] [Related]
34. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
[TBL] [Abstract][Full Text] [Related]
35. Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.
Zhou L; Yang K; Andl T; Wickett RR; Zhang Y
J Cancer; 2015; 6(8):717-26. PubMed ID: 26185533
[TBL] [Abstract][Full Text] [Related]
36. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
37. Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development.
Zhou L; Yang K; Randall Wickett R; Zhang Y
Cancer Med; 2016 Jul; 5(7):1566-79. PubMed ID: 27061029
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
39. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
40. Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
Hossain SM; Eccles MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
